Skip to main content

datastreet.in

Canada approves DRL’s Ozempic generic after months of regulatory logjam

DRL is the first company to receive market authorisation for a generic semaglutide injection in Canada. It is the first generic semaglutide to be approved in a G7 country

Source :- Companies Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *